DavidMacPherson

Cancer Biologist @fredhutch

[DavidMacPherson @DMacPhersonLab]

📣The MacPherson lab @fredhutch is hiring a postdoc to study the biology of small cell lung cancer. We employ in vivo models, genetic screens and genomic approaches to understand + therapeutically target subsets of SCLC. $78K salary ⬆️ to >$90K after 2 yrs
https://t.co/pB0DbKd9ct

[Hsieh Lab @HsiehLab]

The Division of Human Biology @fredhutch is recruiting for a lab-based scientist at the Assistant or Associate Professor level. Come join a dynamic research community committed to pushing the boundaries of discovery in cancer biology. https://t.co/jAnG2L3YHJ

[DavidMacPherson @DMacPhersonLab]

Thanks for highlighting our efforts to use in vivo CRISPR screens to identify drivers of resistance to chemotherapy in small cell lung cancer

[Fred Hutch Cancer Center @fredhutch]

In work published in Science Advances, researchers in the @DMacPhersonLab used #CRISPRCas9 on #SCLC tumor cells to better model how tumors that initially respond to chemotherapy become resistant. https://t.co/ls80zdrdWD

[DavidMacPherson @DMacPhersonLab]

@kyleconcannon4 @aliceb_phd @fredhutch Thanks much Kyle, and great to see your SCLC work progressing nicely!

[DavidMacPherson @DMacPhersonLab]

📣The MacPherson lab @fredhutch is hiring a postdoc to study the biology of small cell lung cancer. We employ in vivo models, genetic screens and genomic approaches to understand + therapeutically target subsets of SCLC. $78K salary ⬆️ to >$90K after 2 yrs
https://t.co/pB0DbKd9ct

[DavidMacPherson @DMacPhersonLab]

@kimia_motlagh Yes! We're very open to MD applicants and have had a number of MD's train in our lab in the past

[DavidMacPherson @DMacPhersonLab]

This work was possible only because of the contributions of our collaborators – Anish Thomas, @charlesrudin, Keith Eaton, McGarry Houghton, Caroline Dive, as well as SCLC patients and funding from NCI and @KuniFoundation 14/14

[DavidMacPherson @DMacPhersonLab]

Our collaborative study with @GavinHa @fredhutch is out in @ScienceAdvances. Led by Joe Hiatt and Anna Lisa Doebley, we developed a liquid biopsy approach, SCLCpheno-seq, to classify SCLC subsets and distinguish from NSCLC based on analyses of ctDNA 1/X https://t.co/NXecntP4qF

[DavidMacPherson @DMacPhersonLab]

Our fragmentomics approach complements other emerging strategies towards SCLC liquid biopsy phenotyping such as DNA methylation analyses and ChIPseq approaches. We advocate for broad application of different phenotyping approaches to patient samples 13/X.

[DavidMacPherson @DMacPhersonLab]

@triparnasen @fredhutch @aliceb_phd @lcsmchat @IcahnMountSinai Thanks for a great visit, Triparna - exciting science presented at the Hutch and at the SWOG meeting!